Author/Authors :
Kıplapınar, Neslihan Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital - Department of Pediatric Cardiology, Turkey , Erek, Ersin Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital - Department of Pediatric Cardiovascular Surgery, Turkey , Ödemiş, Ender Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital - Department of Pediatric Cardiology, Turkey , Öztürk, Erkut Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital - Department of Pediatric Cardiology, Turkey
Abstract :
The modified Blalock-Taussig (mBT) shunt is a palliative surgical treatment that increase pulmonary blood flow in patients with cyanotic congenital heart diseases. The incidence of mBT shunt thrombosis is reported to be among 1-17% (1). Several risk factors were defined about shunt thrombosis such as small age, low body weight, hypoplastic pulmonary arteries, small graft size and thrombophilia (1). We present a case of recurrent mBT shunt thrombosis associated with elevations in anticardiolipin antibody levels.
